PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

LinkedIn

ADA Obesity Association Releases 2026 Adult Obesity Diagnosis and Staging Standards

Standards of Care in Overweight and Obesity 2026American Diabetes Association Obesity AssociationobesityoverweightBMIwaist circumferenceobesity pharmacotherapyweight-promoting medications Endocrinology / Obesity

Background Information

New obesity guidelines emphasize early screening and tailored diagnosis.

Obesity significantly increases the risk of chronic diseases and mortality, making early and accurate diagnosis essential for effective management. The guidelines recommend annual screening for excess adiposity using body mass index (BMI) with race- and ethnicity-specific thresholds for accurate diagnosis. Using these guidelines can improve early intervention strategies, risk assessment, and personalized management plans for adults with obesity. Annual screening and race-specific BMI criteria are key to effective obesity management.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: American Diabetes Association Professional Practice Committee for Obesity

Citation: American Diabetes Association Professional Practice Committee for Obesity Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity-2026. BMJ open diabetes research & care. 2026;13(Suppl 1). doi:10.1136/bmjdrc-2026-006247

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →